RELATIONSHIP BETWEEN LANGUAGE-LITERACY SKILLS AND MENTAL HEALTH
RESEARCHER PROFILE (Filmed April 2024)
Associate Professor Amanda Neil
Select Foundation Principal Research Fellow
Menzies Institute for Medical Research
University of Tasmania &
Health Economics Lead,
Alive National Centre for Mental Health Research Translation
Australia
A/Prof Amanda Neil is a Select Foundation Principal Research Fellow, Menzies Institute for Medical Research, and the health economics lead for the ALIVE National Centre for Mental Health Research Translation. Amanda commenced work in the field of health economics in 1991, and has worked in academia, government and for industry. She was a Member of the Pharmaceutical Benefits Advisory Committee Economics Sub-Committee between 2000 and 2007.
Since commencing at Menzies in 2013, Amanda has established a research program focused on health services and systems, including innovative funding mechanisms and service provision within Tasmania. In 2019, Amanda established the Menzies Mental Health and Wellbeing Research Group to support university and sector wide mental health research in Tasmania. These efforts now include a collaboration with the recently established Tasmanian Centre for Mental Health Service Innovation, including on the current project.
In an innovative move towards enhancing mental health services, Associate Professor Amanda Neil and team, supported by the RHH Research Foundation, are undertaking a crucial study on language-literacy skills of patients within mental health care settings. This year-long project, which commenced in April 2024, seeks to unravel to what extent, where and for whom language-literacy skills are being considered in Tasmanian mental health service provision.
The current project is one Amanda is very passionate about, given her own experience as the mum of a child who experienced significant delays in learning to speak, read and write. This experience leading to her involvement in the 2017 and 2018 Heart of Literacy Symposiums led by 2017 Tasmanian of the Year, Ms Rosalie Martin. Subsequently, A/Prof Isabelle Bartkowiak-Theron, Tasmanian Institute of Law Enforcement and Amanda received philanthropic funding to establish a research program on language-literacy as a social determinant of health and a pathway to resilience and desistence. The current project is extending this foundational work into the domain of mental health service provision.
-
Tyrosine Kinases in cancer recurrence
Dr Yu Yu leads the Oncology and Gynaecology Research Program at Curtin Medical Research Institute . Dr Yu is also a senior research fellow at Curtin Medical School.
Dr Yu Yu’s laboratory is working on better ways to treat cancers, particularly ovarian cancers which are resistant to conventional chemotherapy. The aims are for better informed treatment choice and reducing unnecessary exposure to ineffective chemotherapy and its potential adverse effects.
-
Identification & characterisation of molecular drivers of therapeutic resistance
Professor Pieter Eichhorn is an internationally experienced cancer biologist and research leader whose career has been defined by high-impact contributions at the interface of functional genomics, translational oncology, and research infrastructure strategy.
He completed his PhD at the University of Newcastle upon Tyne, contributing to the cloning of the gene associated with Cornelia de Lange Syndrome, before undertaking postdoctoral training at the Netherlands Cancer Institute in the laboratory of René Bernards. There, he performed pioneering functional genetic screens that identified key regulators of oncogenesis and therapy resistance, including critical roles for the PI3K signalling pathway in resistance to targeted breast cancer therapies.
-
Radiation therapy techniques and combination treatments for sarcoma
Professor Angela Hong MBBS, MMed, PhD, FRANZCR is a Professor at Sydney Medical School of the University of Sydney. She is a radiation oncologist and has been a member of the Multidisciplinary Bone and Soft Tissue Tumour Clinic at Royal Prince Alfred Hospital/Chris O’Brien Lifehouse for the past 15 years.
As a radiation oncologist located in Sydney, Australia, Professor Hong is focused on treating patients with bone and soft tissue sarcoma. And as a clinician scientist, her research focuses on developing innovative radiation therapy technique and combination treatments to improve the outcome for patients with sarcoma.
